Where does Unity Biotechnology, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Unity Biotechnology, Inc. ranks #7,954 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Unity Biotechnology, Inc. hold?

Unity Biotechnology, Inc. holds 41 US utility patents granted between 2017 and 2025, spanning 10 technology areas.

What is Unity Biotechnology, Inc.'s Innovation Score?

Unity Biotechnology, Inc. has an Innovation Score of 33.8 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Unity Biotechnology, Inc. focus on?

Unity Biotechnology, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 35 patents, ranking #541 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Unity Biotechnology, Inc.'s patent grant rate increasing or decreasing?

Unity Biotechnology, Inc.'s recent grant velocity is -27% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Unity Biotechnology, Inc.'s patents?

Unity Biotechnology, Inc.'s patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Unity Biotechnology, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Unity Biotechnology, Inc.

USPTO PatentsView assignee record - 41 granted patents across 10 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Unity ranks #7,954 of 49,997 tracked US assignees by granted-patent volume, with 41 patents across 10 technology areas.

#7,954
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.8/100): 13.9
avg claims per patent: -27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7954 · US Corporation #7,954 · 41 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 41 grants
UPPER-Q #7,954/49,997
PHOTO-FINISH True Velocity
CPC-FOCUS A61P · 10 areas
INNOV-THIN 33.8/100
CLAIMS-RICH 13.9 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: True Velocity, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Unity’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.9 pts (38%) Velocity 1.3 pts (4%) Breadth 11.2 pts (33%) Claim depth 8.4 pts (25%)

Qualcomm Incorporated · highest

85
Respivert · near

34
Hitachi Aloka Medical · near

34
Shazam Investments · near

34
Unity Biotechnology · this assignee

34
Woodward L'Orange · near

34
3D Lighting… · lowest

7

What this shows Unity's Innovation Score is 33.8/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Unity?

Each dot is one of Unity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Unity’s own 13.9 claims/patent is ABOVE the 13.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Unity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Unity's grants concentrate

Unity Biotechnology, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 85.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (14 grants) versus a trough of 1 in 2017. By volume, Unity sits between True Velocity, Inc. and Vitaworks IP, LLC.

Unity's three-year grant acceleration

From 2019–2021 to 2022–2024, Unity Biotechnology, Inc. moved from 25 to 5 grants (0.20x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

True Velocity

41
Twistlock

41
Universiteit Leid…

41
UniversitÉ Joseph…

41
University of Sha…

41
Voyager Therapeut…

41
Versa Networks

41
Vitaworks IP

41
Unity Biotechnolo… ◀

41

What this shows Unity holds 41 patents at rank #7,956, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Unity

By rank, the assignees closest to #7,956 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Unity's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Unity, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Unity ranks #541 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Hitachi Aloka Medical, Ltd. 34 Shazam Investments Ltd. 34 Woodward L'Orange GmbH 34 Respivert Ltd. 34

Unity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Unity Biotechnology, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	2.4%
2018	7	17.1%
2019	14	34.1%
2020	8	19.5%
2021	3	7.3%
2022	1	2.4%
2024	4	9.8%
2025partial year	3	7.3%

Which technologies does Unity Biotechnology, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 35

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 32

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 23

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 17

C07D - Heterocyclic Compounds 9

C07K - Peptides 6

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 6

C12Y - Enzymes 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Unity Biotechnology, Inc.'s patent record in context - here's where to go next.

Unity Biotechnology, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 85.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,954 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Unity Biotechnology, Inc. against True Velocity, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.